Literature DB >> 21166700

Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas.

Luis O González1, Salomé González-Reyes, Laura Marín, Lucía González, José M González, Maria L Lamelas, Antonio M Merino, Elena Rodríguez, Iván Pidal, José M del Casar, Alejandro Andicoechea, Francisco Vizoso.   

Abstract

AIMS: Matrix metalloproteases (MMPs) and their inhibitors (TIMPs) play an essential role in the degradation of stromal connective tissue and basement membrane components. The aim of this study was to determine whether the dynamic analysis of these components can help to predict tumour aggressiveness. METHODS AND
RESULTS: An immunohistochemical study was performed using tissue arrays and specific antibodies against MMPs -1, -2, -7, -9, -11, -13 and -14 and TIMPs -1, -2 and -3. More than 5000 determinations on cancer specimens from 124 patients with invasive breast cancer were performed on the tumour centre core as well as on the invasive front. Immunostaining for MMPs/TIMPs on mononuclear inflammatory cells (MICs) was evaluated. To identify specific groups of tumours with distinct expression profiles, data obtained from both MICs populations were analysed by unsupervised hierarchical cluster analysis. When compared with MICs at the invasive front, intratumour MICs more frequently showed expression of MMP-7 and -1 and TIMP-3, but less frequently expression of MMP-9 and -11 and TIMP-2.
CONCLUSIONS: Our data led us to consider the need of further studies in order to identify subsets of MICs and other protein elements of the microenvironment as attractive targets for new therapeutic strategies against cancer.
© 2010 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166700     DOI: 10.1111/j.1365-2559.2010.03723.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.

Authors:  Noemí Eiró; Belen Fernandez-Garcia; Julio Vázquez; José M Del Casar; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2015-01-29       Impact factor: 8.110

4.  Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.

Authors:  Noemi Eiro; Lucía González; Anxo Martínez-Ordoñez; Belen Fernandez-Garcia; Luis O González; Sandra Cid; Francisco Dominguez; Román Perez-Fernandez; Francisco J Vizoso
Journal:  Cell Oncol (Dordr)       Date:  2018-03-01       Impact factor: 6.730

5.  Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.

Authors:  Debika Bhattacharya; Nabiha Yusuf
Journal:  Int J Breast Cancer       Date:  2011-11-09

6.  MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.

Authors:  Noemi Eiro; Sandra Cid; Nuria Aguado; María Fraile; Nagore de Pablo; Berta Fernández; Francisco Domínguez; Luis O González; Francisco J Vizoso
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

7.  Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype.

Authors:  Andrzej Ciereszko; Mariola A Dietrich; Mariola Słowińska; Joanna Nynca; Michał Ciborowski; Monika M Kaczmarek; Kamil Myszczyński; Joanna Kiśluk; Anna Majewska; Anna Michalska-Falkowska; Natalia Kodzik; Joanna Reszeć; Ewa Sierko; Jacek Nikliński
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

8.  Gene Expression Profile of Stromal Factors in Cancer-Associated Fibroblasts from Prostate Cancer.

Authors:  Noemi Eiro; Jesús María Fernández-Gómez; Cristina Gonzalez-Ruiz de León; Maria Fraile; Jorge Gonzalez-Suarez; Beatriz Lobo-Rodríguez; Jorge García-Rodríguez; Safwan Escaf; Francisco J Vizoso
Journal:  Diagnostics (Basel)       Date:  2022-06-30

9.  Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.

Authors:  Noemí Eiró; Iván Pidal; Belen Fernandez-Garcia; Sara Junquera; Maria L Lamelas; José M del Casar; Luis O González; Alfonso López-Muñiz; Francisco J Vizoso
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.